These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7684650)

  • 1. Relationship between prostate specific antigen, prostate volume and age in the benign prostate.
    Collins GN; Lee RJ; McKelvie GB; Rogers AC; Hehir M
    Br J Urol; 1993 Apr; 71(4):445-50. PubMed ID: 7684650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia.
    Roehrborn CG; Boyle P; Gould AL; Waldstreicher J
    Urology; 1999 Mar; 53(3):581-9. PubMed ID: 10096388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between serum prostate specific antigen concentration and prostate volume.
    Yu HJ; Chiang GJ; Chiu TY; Lai MK
    J Formos Med Assoc; 1995 Nov; 94(11):666-70. PubMed ID: 8527973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of prostate volume based on total and free serum prostate-specific antigen: is it reliable?
    Morote J; Encabo G; López M; de Torres IM
    Eur Urol; 2000 Jul; 38(1):91-5. PubMed ID: 10859448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.
    Bretton PR; Evans WP; Borden JD; Castellanos RD
    Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between prostate-specific antigen, prostate volume, retention volume and age in benign prostatic hypertrophy (BPH).
    Dutkiewicz S; Witeska A; Stepień K
    Int Urol Nephrol; 1995; 27(6):763-8. PubMed ID: 8725044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of digital rectal examination and serum prostate specific antigen in the estimation of prostate volume in community-based men aged 50 to 78 years: the Krimpen Study.
    Bosch JL; Bohnen AM; Groeneveld FP
    Eur Urol; 2004 Dec; 46(6):753-9. PubMed ID: 15548443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
    Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A
    Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
    Men S; Cakar B; Conkbayir I; Hekimoglu B
    J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
    Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
    Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with an assay for prostate-specific antigen and transrectal ultrasonography in the diagnosis of prostate cancer.
    Heman-Ackah CA; Festenstein JB; Hibbert P; Harvey DJ; Bunce CJ; Gelister JS
    Br J Urol; 1997 Mar; 79(3):439-44. PubMed ID: 9117228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms.
    Vesely S; Knutson T; Damber JE; Dicuio M; Dahlstrand C
    Scand J Urol Nephrol; 2003; 37(4):322-8. PubMed ID: 12944191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.
    Haese A; Graefen M; Noldus J; Hammerer P; Huland E; Huland H
    J Urol; 1997 Dec; 158(6):2188-92. PubMed ID: 9366341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relationship of PSA to age and prostatic volume in patients with benign prostatic hypertrophy].
    Sánchez Sánchez E; Paez Borda A; Herrero Payo A; Ruiz Rubio JL; Acebal Lucía J; Berenguer Sánchez A
    Actas Urol Esp; 1995 Mar; 19(3):181-6. PubMed ID: 8659273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution.
    Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
    BJU Int; 2005 Jun; 95(9):1245-8. PubMed ID: 15892809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between serum prostate-specific antigen and prostate volume in Korean men with benign prostatic hyperplasia: a multicentre study.
    Chung BH; Hong SJ; Cho JS; Seong DH
    BJU Int; 2006 Apr; 97(4):742-6. PubMed ID: 16536765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early diagnosis of prostate carcinoma with reference to the density of prostate-specific antigen].
    Schmid HP; Ravery V; Toublanc M; Boccon-Gibod L
    Schweiz Med Wochenschr; 1996 Sep; 126(36):1530-5. PubMed ID: 8927956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels.
    Schmid HP; Ravery V; Billebaud T; Toublanc M; Boccon-Gibod LA; Hermieu JF; Delmas V; Boccon-Gibod L
    Urology; 1996 May; 47(5):699-703. PubMed ID: 8650868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate specific antigen in a community-based sample of men without prostate cancer: correlations with prostate volume, age, body mass index, and symptoms of prostatism.
    Bosch JL; Hop WC; Bangma CH; Kirkels WJ; Schröder FH
    Prostate; 1995 Nov; 27(5):241-9. PubMed ID: 7479391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen corrected for prostate volume improves differentiation of benign prostatic hyperplasia and organ-confined prostatic cancer.
    Semjonow A; Hamm M; Rathert P; Hertle L
    Br J Urol; 1994 May; 73(5):538-43. PubMed ID: 7516808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.